Subvisible particulate matter is under increasing amounts of scrutiny in the field of parenteral and ophthalmic drug products. USP <1788> and <1788.3> explicitly recommend the use of flow imaging and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results